Envista Holdings Corp (NVST)

NYSE • Healthcare

$23.6

-$0.36 (-1.5%)

Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$23.82

Day Range$23.52 - $24.1

Avg. Volume (3M)2.7M

Market Cap$3.7B

P/E Ratio40.0

52 Week Range

$18.77$30.42

Next EarningsIn 12 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q3 2026

Revenueeverything earned$730.5M100%

Gross Profitminus cost of goods$407M56%

Operating Incomeminus R&D and overhead$80.3M11%

Net Incomeminus taxes and the rest$53.7M7%

In plain terms: out of every $100 in revenue, Envista Holdings Corp keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)

$2.8B

Net Income (TTM)

$95M

EPS (TTM)

$0.59

ROA (TTM)

1.7%

Current Ratio

2.43

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+8.3%Q3 2025$0.26

+18.5%Q4 2025$0.32

+18.8%Q1 2026$0.38

+16.1%Q2 2026$0.36

+22.3%Q3 2026$0.41

Nov 4

in 12 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +22.3%

Envista Holdings beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported Aug. 5. Revenue rose 7.1% to about $730.5 million, topping the $716.1 million consensus by 2.0%, while gross margin held at 55.7% and operating margin was 11.0% as operating income came to about $80.3 million. Adjusted EPS of $0.41, up 57.7% from $0.26 a year ago, beat the $0.34 estimate by 22.3%. Net income increased 103.4% to about $53.7 million from $26.4 million a year earlier. The company generated operating cash flow of $115.9 million and repurchased $103.0 million of stock. Consensus for the next period calls for EPS of $0.34 on revenue of $694.2 million.

Next report — what to expect

Envista Holdings Corp (NVST) reports on November 4, 2026. Wall Street is looking for EPS of $0.357 on revenue of $690.2 million. For trailing context, revenue grew +7.1% year over year last quarter. Envista has beaten EPS in 8 of 8 most recent quarters, making commentary around drivers and margins a key watch.

View full earnings history

About Envista Holdings Corp

Envista Holdings Corp trades on the NYSE under NVST and operates in healthcare as a maker of dental equipment, supplies, and software. The company generated $2.7 billion of revenue in FY2025 from products used to identify, treat, and help prevent oral health problems affecting teeth, gingiva, and supporting bone structures.

Name

Envista Holdings Corp

CEO

Paul A. Keel

Website

www.envistaco.com

Industry

Healthcare

Employees

12,000

Today's Snapshot

AI-generated

NVST closed 1.5% lower at 23.60, in line with a weaker sector. Earnings are due from NVST on 4 November.

Trading Volume

Below 10d avg (3.1M)

2.7M

vs S&P 500 Today

Underperforming Market

-1.02%

Updated: October 23, 2026 at 20:19 UTC

Technical Indicators

2 Buy3 Neutral3 Sell

NVST exhibits short-term support yet longer-term pressure, with price trading around the 10–20-day averages while the 50/100/200-day levels sit noticeably higher, implying medium-term resistance. Momentum indicators are mixed—CCI is strong but RSI and MACD are neutral—and ADX near the mid-20s signals a developing trend rather than a clear directional run. Volatility is low relative to price and OBV is firmly positive, pointing to constructive volume despite the longer-term moving-average overhead. Technical takeaway: Sell.

All signals